Good Afternoon. On this day in 1977, Radio Shack introduced the TRS-80, a little computer that helped move computing from the office into the home.

Today’s market found its own “back in business” moment: factories sped up, dealmakers stayed busy, and investors didn’t need much convincing once oil prices cooled.

—Rosie, Wyatt, Evan & Conor

🔥 What’s Hot: 🔥

🥶 What’s Not: 🥶

🔢 Big number: 55.6 — That’s July’s U.S. manufacturing index, its strongest reading since May 2022. Demand is improving, but a price gauge above 70 says the comeback isn’t cost-free.

U.S. manufacturing isn’t merely hanging on anymore. July’s survey showed orders, production, and hiring expanding together, which gives the broader economy a sturdier foundation than a rally built only on hopes and headlines.

The news: The Institute for Supply Management’s manufacturing index climbed to 55.6 from 53.3, its highest level since May 2022. Production jumped to 58.5, while employment returned to growth for the first time in 33 months. It’s not all frictionless: the prices index remained elevated at 71.1, and supplier deliveries slowed again.

What’s next: Customers’ inventories are still considered too low, so factories may have room to refill shelves if new orders hold. Businesses shouldn’t mistake stronger volume for easier margins, though; metals, electronics, tariffs, and transportation costs can still turn a good demand month into a difficult pricing conversation.

Source: Institute for Supply Management

Boeing finally won U.S. approval for the smallest 737 Max, but the milestone doesn’t erase nearly a decade of delay. It does give airlines another option for routes that can’t always fill a larger narrow-body jet.

The news: The Federal Aviation Administration approved the 737 Max 7 for commercial service after requiring changes involving flight software, cockpit alerts, and engine anti-ice systems. It wasn’t a quick finish: Boeing unveiled the model in 2016, and certification repeatedly slipped as regulators increased scrutiny after the Max crashes and later manufacturing problems.

Big picture: Approval lets Boeing move toward delivering a long backlog, including planes ordered by Southwest, but execution still matters more than a certificate. The company can’t rebuild trust with one model launch; it’ll need consistent production quality, dependable deliveries, and a clean path for the larger Max 10.

Source: Associated Press

Tyson Foods is showing why a mixed protein portfolio can matter when consumers trade down. Beef remains expensive and difficult, but chicken and prepared foods are doing enough work that the company’s overall profit picture improved.

The news: Quarterly sales were roughly flat at $13.9 billion, while adjusted operating income rose 8% to $547 million and adjusted earnings reached $0.99 per share. It’s a split-screen business: Tyson expects its beef unit to lose $500 million–$650 million this year, while chicken could earn as much as $2.05 billion in adjusted operating income.

Bottom line: Households don’t stop buying protein when budgets tighten; they change the mix. Tyson’s stronger categories can cushion cattle shortages and high beef costs, but shoppers should expect those supply pressures to linger. The company will have to keep its chicken operations efficient without assuming consumers can absorb every price increase.

Source: Tyson Foods

Visa isn’t buying another card network with its $2.4 billion BioCatch deal. It’s buying behavioral clues—how someone types, swipes, and handles a device—that can help banks spot an impostor before a suspicious payment becomes an expensive cleanup.

The news: BioCatch uses behavioral biometrics and device intelligence to distinguish normal account activity from fraud, an increasingly useful layer as artificial intelligence makes scams more convincing. The acquisition won’t be only about stopping stolen-card purchases; it expands Visa’s faster-growing services business and gives financial institutions another tool against account takeovers and manipulated customers.

What’s next: Fraud prevention is becoming less about recognizing a bad transaction and more about recognizing when a good customer isn’t acting like themselves. Banks will still need transparent rules, privacy controls, and human review because unusual behavior isn’t automatically criminal. Visa’s task is to turn BioCatch’s signals into fewer losses without creating more false alarms.

Source: CNBC

Curium’s planned purchase of Lantheus isn’t a conventional drug merger. The combination would connect radioactive-isotope manufacturing, diagnostic imaging, and targeted treatments across more than 70 countries, giving a specialized field more scale from factory to patient.

The news: Curium agreed to pay $102.50 in cash for each Lantheus share, plus up to $12 more through contingent value rights tied to product sales milestones. That puts the potential transaction value near $8 billion. The extra payment isn’t guaranteed, and the deal still needs shareholder and regulatory approvals before an expected first-half 2027 close.

Big picture: Radiopharmaceuticals can be commercially powerful, but short-lived isotopes make manufacturing and distribution unusually important. That’s why the strategic fit matters as much as the headline price. If the merger closes, investors and hospitals should watch whether a broader supply network improves access without reducing competition in a fast-growing medical niche.

Source: GlobeNewswire via StockTitan

Oil prices fell sharply after President Trump cancelled a planned attack on Iran, saying negotiations had made progress. Relief isn’t the same as a durable peace, but even a lower chance of immediate escalation can remove part of the premium embedded in every barrel.

The news: U.S. officials had prepared military options before Trump called off the strike, while Gulf allies urged restraint and talks continued. The decision didn’t settle the dispute, yet it helped push crude down more than 5% and back toward $80 a barrel as traders reduced bets on another disruption to Middle Eastern supply.

Bottom line: Cheaper crude can lower fuel, freight, and eventually some goods costs, which is why airlines rose while energy shares lagged. Businesses won’t want to lock in a one-day reprieve as a permanent forecast. Negotiating progress matters, but shipping routes, regional retaliation, and the next diplomatic deadline can put the risk premium back quickly.

Source: Axios

Japan and the United States confirmed they intervened together to strengthen the yen, a rare partnership that doesn’t change Japan’s fundamentals overnight. It does tell currency markets that officials have a line they’re willing to defend when imported inflation becomes too painful.

The news: The dollar had traded above 163 yen before the intervention, then fell below 160 and reached roughly 155 early Monday before partially rebounding. The move wasn’t just symbolic: a stronger yen makes imported energy and food less expensive for Japan, though it can also reduce the overseas earnings advantage enjoyed by exporters.

What’s next: Traders shouldn’t assume one intervention permanently reverses a currency trend driven by interest-rate differences. Japan’s inflation data and central-bank policy will still do most of the long-term work. Companies with yen exposure may want to review hedges now, because officials have shown they don’t plan to watch every disorderly move from the sidelines.

Source: Associated Press

The eurozone’s manufacturing recovery is getting broader, even if it isn’t completely comfortable. July’s factory gauge reached its best level in more than four years as output accelerated, but cautious purchasing suggests businesses still don’t trust the international backdrop enough to stock up aggressively.

The news: The region’s manufacturing index rose to 51.9, up half a point from June and its highest since April 2022. Factory output grew at its fastest pace since March 2022, while country results remained uneven and purchasing activity continued to decline. It’s growth with one foot near the brake, especially while energy and trade risks remain unsettled.

Big picture: Europe’s improvement matters because a synchronized factory rebound can support trade, hiring, and investment beyond the U.S. That’s encouraging, but the weak purchasing signal says managers are protecting cash and waiting for clearer demand. A durable expansion will need more new orders and steadier input costs, not just another strong production month.

Source: Cinco Días

Q: Why’d the two fractions merge?

A: They found out they had a common denominator.

How well two companies’ products, capabilities, and markets complement one another after a combination.

In a sentence: Today’s Curium-Lantheus deal has a clear strategic fit because one side’s global isotope network could extend the other’s U.S. diagnostic reach.

Tech Moves Fast. TLDR Helps You Keep Up.

From AI breakthroughs to startup trends and market-moving innovation, technology is reshaping how businesses grow and investors think. TLDR gives 1.6 million readers a quick daily breakdown of the most interesting stories in tech, startups, and programming. It’s a simple way to stay ahead of the trends driving the future economy. Sign-up here.